Display options
Cite
Mestres C, Agustí A, Hernandez M, et al. Pharmacist Intervention Program at Different Rent Levels of Geriatric Healthcare. Pharmacy (Basel). 2017;5(2)doi: 10.3390/pharmacy5020027.
Mestres, C., Agustí, A., Hernandez, M., Puerta, L., & Llagostera, B. (2017). Pharmacist Intervention Program at Different Rent Levels of Geriatric Healthcare. Pharmacy (Basel, Switzerland), 5(2), . https://doi.org/10.3390/pharmacy5020027
Mestres, Conxita, et al. "Pharmacist Intervention Program at Different Rent Levels of Geriatric Healthcare." Pharmacy (Basel, Switzerland) vol. 5,2 (2017). doi: https://doi.org/10.3390/pharmacy5020027
Mestres C, Agustí A, Hernandez M, Puerta L, Llagostera B. Pharmacist Intervention Program at Different Rent Levels of Geriatric Healthcare. Pharmacy (Basel). 2017 May 19;5(2). doi: 10.3390/pharmacy5020027. PMID: 28970439; PMCID: PMC5597152.
Copy Download .nbib Format: NLM
Share it on

Pharmacy (Basel). 2017 May 19;5(2). doi: 10.3390/pharmacy5020027.

Pharmacist Intervention Program at Different Rent Levels of Geriatric Healthcare.

Pharmacy (Basel, Switzerland)

Conxita Mestres, Anna Agustí, Marta Hernandez, Laura Puerta, Blanca Llagostera

Affiliations

  1. School of Health Sciences Blanquerna, University Ramon Llull, Padilla 326, 08025 Barcelona, Spain. [email protected].
  2. Pharmacy Service, HSS Mutuam Girona, Avinguda de França 64, 17007 Girona, Spain. [email protected].
  3. Pharmacy Service, EAR Grup Mutuam, Ausias March 39, 08010 Barcelona, Spain. [email protected].
  4. Pharmacy Service, HSS Mutuam Güell, Mare de Deu de la Salut 49, 08024 Barcelona, Spain. [email protected].
  5. Pharmacy Service, EAR Grup Mutuam, Ausias March 39, 08010 Barcelona, Spain. [email protected].

PMID: 28970439 PMCID: PMC5597152 DOI: 10.3390/pharmacy5020027

Abstract

As a pharmacy service giving pharmaceutical care at different levels of health care for elderly people, we needed a standardization procedure for recording and evaluating pharmacists' interventions. Our objective was to homogenize pharmacist interventions; to know physicians' acceptance of our recommendations, as well as the most prevalent drug related problems (DRP); and the impact of the pharmacists' interventions. To achieve this goal we conducted a one year prospective study at two levels of health care: 176 nursing homes (EAR) (8828 patients) and 2 long-term and subacute care hospitals (HSS) (268 beds). Pharmacists' interventions were recorded using the American Society of Health-System Pharmacists classification as the basis. Frequency of the different DRP and the level of response and acceptance on the part of physicians was determined. The Medication Appropriateness Index (MAI) was used to evaluate the impact of the interventions on the prescription quality. Patients' mean age was 84.2 (EAR) and 80.7 (HSS), and in both cases, polypharmacy ≥ 9 drugs was around 63-69%. There were 4073 interventions done in EAR and 2560 in HSS. Level of response: 44% (EAR), 79% (HSS); degree of acceptance of the recommendations: 84% (EAR), 72% (HSS). Most frequent DRP: inappropriate dose, length of therapy, omissions, and financial impact. Drugs for the nervous system are those with the most DRP. MAI values/medication improved from 4.4 to 2.7 (EAR) and 3.8 to 1.7 (HSS). A normalized way of managing pharmacists' interventions for different health care levels has been established. We are on the way to increasing collaborative work with physicians and we know which DRPs are most prevalent.

Keywords: drug related problems; geriatrics; inappropriate medication; pharmacists’ interventions

Conflict of interest statement

The authors declare no conflict of interest.

References

  1. Ann Pharmacother. 2004 May;38(5):859-67 - PubMed
  2. Cochrane Database Syst Rev. 2013 Feb 28;(2):CD009095 - PubMed
  3. Pharmacotherapy. 2000 Aug;20(8):991-1020 - PubMed
  4. Am J Health Syst Pharm. 1996 Jul 15;53(14):1713-6 - PubMed
  5. BMC Health Serv Res. 2014 Apr 17;14:177 - PubMed
  6. Value Health. 2011 Jan;14(1):34-40 - PubMed
  7. Int J Clin Pharm. 2011 Jun;33(3):549-57 - PubMed
  8. Drugs Aging. 2008;25(11):947-54 - PubMed
  9. J Gerontol A Biol Sci Med Sci. 2012 Jun;67(6):698-704 - PubMed
  10. Am J Health Syst Pharm. 2007 Dec 1;64(23):2483-7 - PubMed
  11. Am J Hosp Pharm. 1993 Aug;50(8):1585-656 - PubMed
  12. Drugs Aging. 2013 Nov;30(11):893-900 - PubMed
  13. Pharm World Sci. 2002 Apr;24(2):46-54 - PubMed
  14. Lancet. 2007 Jul 14;370(9582):173-84 - PubMed
  15. J Clin Epidemiol. 1992 Oct;45(10):1045-51 - PubMed

Publication Types